Montpellier, France

Cyril Sarrauste De Menthiere

This inventor holds 1 USPTO granted patent. Top assignee: Les Laboratoires Servier. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cyril Sarrauste De Menthiere. Retrieved from https://idiyas.com/inventor/cyril-sarrauste-de-menthiere

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 90(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Cyril Sarrauste de Menthiere

Introduction:

Cyril Sarrauste de Menthiere, a talented inventor hailing from Montpellier, France, is making his mark in the field of pharmaceuticals with his groundbreaking work in peptide compounds.

Latest Patents:

With a total of 1 patent to his name, Cyril's most notable invention is the peptide compounds analogues of the glucagon-like peptide-1 (7-37). This patent showcases his expertise and dedication to advancing medical research.

Career Highlights:

Cyril Sarrauste de Menthiere is currently associated with Les Laboratoires Servier, a renowned pharmaceutical company known for its innovative contributions to the healthcare industry. His collaboration with the company has led to significant advancements in drug development.

Collaborations:

Throughout his career, Cyril has worked closely with esteemed colleagues such as Bernard Calas and Gérard Grassy, who have made valuable contributions to his research endeavors. Their collaboration has fostered a creative and productive work environment, resulting in the successful creation of pioneering pharmaceutical solutions.

Conclusion:

In conclusion, Cyril Sarrauste de Menthiere's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of pharmaceutical inventions. His groundbreaking work continues to inspire and drive progress in the field of medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…